81 results
CORRESP
ALGS
Aligos Therapeutics Inc
22 Dec 22
Correspondence with SEC
12:00am
party is responsible for covering their own costs and the Company’s costs are not guaranteed to be covered by the upfront payment. Additionally … authorizations for a product in certain countries) and (iii) sales-based milestones. The Company is primarily responsible for designing, preparing
S-3
EX-4.4
ALGS
Aligos Therapeutics Inc
4 Nov 21
Shelf registration
4:57pm
.
“Responsible Officer” means any officer of the Trustee in its Corporate Trust Office having responsibility for administration of this Indenture and also … be Dollars or any Foreign Currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible
10-K
2020 FY
EX-31.2
ALGS
Aligos Therapeutics Inc
23 Mar 21
Annual report
4:26pm
other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
10-Q
EX-31.2
wqadua0
25 Nov 20
Quarterly report
5:21pm
10-K
EX-31.1
boafj7 6fl
23 Mar 21
Annual report
4:26pm
UPLOAD
13ygvlsxiil
27 Dec 22
Letter from SEC
12:00am
UPLOAD
bqruhk0 sf
21 Nov 23
Letter from SEC
12:00am
UPLOAD
gbrvebslrpi3b
10 Jun 21
Letter from SEC
12:00am
UPLOAD
7cxff8r
8 Dec 22
Letter from SEC
12:00am
10-Q
EX-31.1
xa6pifh
25 Nov 20
Quarterly report
5:21pm